Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Science Advisors
Technology
Overview
RAMP™ Drug Innovation Engine
Pipeline
Overview
Risvodetinib (IkT-148009) for Parkinson’s Disease and GI complications
IkT-001Pro for CML
IkT-001Pro for PAH
Collaborative Programs
Partnering with Inhibikase
Scientific Publications
Clinical Trials
News
Press Releases
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact
Careers
Quarterly Reports
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Filing Type:
View All
10-Q
Year:
View All
2024
2023
2022
2021
2020
2018
Date
Form
Description
PDF
XBRL
Pages
05/17/21
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
expand_more
EX-31.1
EX-31.2
EX-32.1
EX-32.2
28
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
Page
2
Select a page:
Page 1
Page 2
Email Alerts
Contacts
RSS News Feed